Plain-English translation of NCT05837260 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Thyroid Cancer research guide →Researchers are investigating whether a blood test can detect tiny pieces of cancer DNA (called ctDNA) in the bloodstream of people with advanced thyroid cancer. This blood test might help doctors spot cancer progression much faster than traditional imaging, and could help explain why some cancers become more aggressive. The study will follow people with four different types of advanced thyroid cancer to see if this blood test can better guide treatment decisions.
Currently, doctors rely on imaging scans and standard blood tests to track thyroid cancer, but these methods can take months to show whether a cancer is growing. Researchers hope this new blood test could detect changes in real time and help them personalize treatment plans based on each person's unique cancer genetics.
You likely qualify if…
You likely don't qualify if…
You will provide blood samples at specific time points — either during your regular clinic visits or at dedicated study appointments — so researchers can test for cancer DNA. Depending on which group you're in, you may be followed during surveillance (regular monitoring without active treatment), at the start of treatment, or while already receiving therapy. The study team will also access your existing tissue samples or may ask you to have a small biopsy if needed, and you'll continue with your standard cancer care as planned by your medical team.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
United Kingdom